GlassScriptPhysician profile
Samuel J Stepanow
NPI 1235249913
$462.88
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $11.86 · 2022: $70.23 · 2023: $73.53 · 2024: $39.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $101.49 | 2022-2024 | Ubrelvy |
| Takeda Pharmaceuticals U.S.A., INC. | $83.65 | 2019-2020 | |
| Pfizer INC. | $65.37 | 2022-2023 | |
| Scilex Pharmaceuticals INC. | $50.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.04 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.61 | 2019 | |
| Astellas Pharma US INC | $27.05 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.74 | 2019 | |
| Amarin Pharma, INC. | $15.22 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.68 | 2019 | |
| Horizon Therapeutics Plc | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Stepanow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.